NCT05235906 2023-08-09
A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Sun Yat-sen University
Phase 2 Unknown
Sun Yat-sen University
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Zhejiang Cancer Hospital
Fujian Cancer Hospital
The Third Affiliated Hospital of Harbin Medical University